Immuron's IMM-124E shows encouraging action in mid-stage NASH study; shares ahead 81%

Top-line data showed treatment with IMM-124E (bovine colostrum) produced a statistically significant reduction in serum lipopolysaccharide (LPS) levels compared to placebo. LPS is associated with the progression of NASH.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.